247 related articles for article (PubMed ID: 27541586)
1. MRI-guided focal laser ablation for prostate cancer followed by radical prostatectomy: correlation of treatment effects with imaging.
Bomers JGR; Cornel EB; Fütterer JJ; Jenniskens SFM; Schaafsma HE; Barentsz JO; Sedelaar JPM; Hulsbergen-van de Kaa CA; Witjes JA
World J Urol; 2017 May; 35(5):703-711. PubMed ID: 27541586
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of tumor coverage after MR-guided prostate focal laser ablation therapy.
Knull E; Oto A; Eggener S; Tessier D; Guneyli S; Chatterjee A; Fenster A
Med Phys; 2019 Feb; 46(2):800-810. PubMed ID: 30447155
[TBL] [Abstract][Full Text] [Related]
3. Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial.
Natarajan S; Raman S; Priester AM; Garritano J; Margolis DJ; Lieu P; Macairan ML; Huang J; Grundfest W; Marks LS
J Urol; 2016 Jul; 196(1):68-75. PubMed ID: 26748164
[TBL] [Abstract][Full Text] [Related]
4. Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy.
Lindner U; Lawrentschuk N; Weersink RA; Davidson SR; Raz O; Hlasny E; Langer DL; Gertner MR; Van der Kwast T; Haider MA; Trachtenberg J
Eur Urol; 2010 Jun; 57(6):1111-4. PubMed ID: 20346578
[TBL] [Abstract][Full Text] [Related]
5. MR imaging-guided focal laser ablation for prostate cancer: phase I trial.
Oto A; Sethi I; Karczmar G; McNichols R; Ivancevic MK; Stadler WM; Watson S; Eggener S
Radiology; 2013 Jun; 267(3):932-40. PubMed ID: 23440319
[TBL] [Abstract][Full Text] [Related]
6. Laser ablation-induced changes in the prostate: findings at endorectal MR imaging with histologic correlation.
Böni RA; Sulser T; Jochum W; Romanowski B; Debatin JF; Krestin GP
Radiology; 1997 Jan; 202(1):232-6. PubMed ID: 8988216
[TBL] [Abstract][Full Text] [Related]
7. T2*-weighted MRI as a non-contrast-enhanced method for assessment of focal laser ablation zone extent in prostate cancer thermotherapy.
Sun C; Wang S; Chatterjee A; Medved M; Eggener S; Karczmar GS; Oto A
Eur Radiol; 2021 Jan; 31(1):325-332. PubMed ID: 32785769
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Focal Laser Ablation of Prostate Cancer Using High Spectral and Spatial Resolution Imaging: A Pilot Study.
Wang S; Fan X; Yousuf A; Eggener SE; Karczmar G; Oto A
J Magn Reson Imaging; 2019 May; 49(5):1374-1380. PubMed ID: 30291653
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Focal Ablation of Magnetic Resonance Imaging Defined Prostate Cancer Using Magnetic Resonance Imaging Controlled Transurethral Ultrasound Therapy with Prostatectomy as the Reference Standard.
Ramsay E; Mougenot C; Staruch R; Boyes A; Kazem M; Bronskill M; Foster H; Sugar L; Haider M; Klotz L; Chopra R
J Urol; 2017 Jan; 197(1):255-261. PubMed ID: 27545572
[TBL] [Abstract][Full Text] [Related]
10. Complications, Recovery, and Early Functional Outcomes and Oncologic Control Following In-bore Focal Laser Ablation of Prostate Cancer.
Lepor H; Llukani E; Sperling D; Fütterer JJ
Eur Urol; 2015 Dec; 68(6):924-6. PubMed ID: 25979568
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
[TBL] [Abstract][Full Text] [Related]
12. Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy.
Wang L; Mazaheri Y; Zhang J; Ishill NM; Kuroiwa K; Hricak H
Radiology; 2008 Jan; 246(1):168-76. PubMed ID: 18024440
[TBL] [Abstract][Full Text] [Related]
13. Fusion of Magnetic Resonance Imaging and Real-Time Elastography to Visualize Prostate Cancer: A Prospective Analysis using Whole Mount Sections after Radical Prostatectomy.
Brock M; Roghmann F; Sonntag C; Sommerer F; Tian Z; Löppenberg B; Palisaar RJ; Noldus J; Hanske J; von Bodman C
Ultraschall Med; 2015 Aug; 36(4):355-61. PubMed ID: 24854132
[TBL] [Abstract][Full Text] [Related]
14. Utility of Multiparametric MRI for Predicting Residual Clinically Significant Prostate Cancer After Focal Laser Ablation.
Felker ER; Raman SS; Lu DSK; Tuttle M; Margolis DJ; ElKhoury FF; Sayre J; Marks LS
AJR Am J Roentgenol; 2019 Dec; 213(6):1253-1258. PubMed ID: 31361529
[No Abstract] [Full Text] [Related]
15. MRI Findings After MRI-Guided Focal Laser Ablation of Prostate Cancer.
Westin C; Chatterjee A; Ku E; Yousuf A; Wang S; Thomas S; Fan X; Eggener S; Karczmar G; Oto A
AJR Am J Roentgenol; 2018 Sep; 211(3):595-604. PubMed ID: 29995499
[TBL] [Abstract][Full Text] [Related]
16. Technical Note: Method to correlate whole-specimen histopathology of radical prostatectomy with diagnostic MR imaging.
McGrath DM; Lee J; Foltz WD; Samavati N; Jewett MA; van der Kwast T; Chung P; Ménard C; Brock KK
Med Phys; 2016 Mar; 43(3):1065-72. PubMed ID: 26936694
[TBL] [Abstract][Full Text] [Related]
17. MR-guided prostate biopsy for planning of focal salvage after radiation therapy.
Ménard C; Iupati D; Publicover J; Lee J; Abed J; O'Leary G; Simeonov A; Foltz WD; Milosevic M; Catton C; Morton G; Bristow R; Bayley A; Atenafu EG; Evans AJ; Jaffray DA; Chung P; Brock KK; Haider MA
Radiology; 2015 Jan; 274(1):181-91. PubMed ID: 25203127
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings.
Villers A; Puech P; Mouton D; Leroy X; Ballereau C; Lemaitre L
J Urol; 2006 Dec; 176(6 Pt 1):2432-7. PubMed ID: 17085122
[TBL] [Abstract][Full Text] [Related]
19. MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy.
van den Bos W; de Bruin DM; van Randen A; Engelbrecht MR; Postema AW; Muller BG; Varkarakis IM; Skolarikos A; Savci-Heijink CD; Jurhill RR; Zondervan PJ; Laguna Pes MP; Wijkstra H; de Reijke TM; de la Rosette JJ
Eur Radiol; 2016 Jul; 26(7):2252-60. PubMed ID: 26449559
[TBL] [Abstract][Full Text] [Related]
20. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
